Gh5 And Gh30 In Wet Milling - EP3658610

The patent EP3658610 was granted to Novozymes on Oct 25, 2023. The application was originally filed on Jul 24, 2018 under application number EP18758985A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3658610

NOVOZYMES
Application Number
EP18758985A
Filing Date
Jul 24, 2018
Status
Granted And Under Opposition
Sep 22, 2023
Publication Date
Oct 25, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DANISCOJul 24, 2024MEWBURN ELLISADMISSIBLE

Patent Citations (36) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0238023
DESCRIPTIONUS5066218
DESCRIPTIONUS5223409
DESCRIPTIONUS6011147
DESCRIPTIONUS6566125
DESCRIPTIONWO0024883
DESCRIPTIONWO0056900
DESCRIPTIONWO0200731
DESCRIPTIONWO0200911
DESCRIPTIONWO0202644
DESCRIPTIONWO2010039889
DESCRIPTIONWO2014082564
DESCRIPTIONWO2014082566
DESCRIPTIONWO2016005522
DESCRIPTIONWO9206204
DESCRIPTIONWO9517413
DESCRIPTIONWO9522625
DESCRIPTIONWO9533836
DESCRIPTIONWO9600787
INTERNATIONAL-SEARCH-REPORTCN104812778
INTERNATIONAL-SEARCH-REPORTWO2014082564
INTERNATIONAL-SEARCH-REPORTWO2016005519
INTERNATIONAL-SEARCH-REPORTWO2016005521
INTERNATIONAL-SEARCH-REPORTWO2016005522
INTERNATIONAL-SEARCH-REPORTWO2018095408
OPPOSITIONCN104812778
OPPOSITIONUS2006003433
OPPOSITIONUS2012288900
OPPOSITIONUS2016040203
OPPOSITIONUS5073201
OPPOSITIONWO2014082564
OPPOSITIONWO2016005519
OPPOSITIONWO2016005521
OPPOSITIONWO2016005522
OPPOSITIONWO2017088820
OPPOSITIONWO2018095408

Non-Patent Literature (NPL) Citations (20) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- D16 - CAZy database for bacteria of genus 'P' - 11 July 2017
OPPOSITION- D19 - Sequence Alignment between Patent SEQ ID NO: 1 and P1 SEQ ID NO: 1
OPPOSITION- D20 - Sequence Alignment between Patent SEQ ID NO: 3 and P1 SEQ ID NO: 3
OPPOSITION- D21 - Sequence Alignment between Patent SEQ ID NO: 6 and P1 SEQ ID NO: 6
OPPOSITION- D22 - Sequence Alignment between Patent SEQ ID NO: 6 and D11 SEQ ID NO: 6
OPPOSITION- D23 - Sequence Alignment between Patent SEQ ID NO: 2 and D4 SEQ ID NO: 12
OPPOSITION- D24 - Sequence Alignment between Patent SEQ ID NO: 4 and D13 SEQ ID NO: 238
OPPOSITION- D25 - Further sequence Alignments between Patent and D2 and D4
OPPOSITION- D26 - Declaration of Xiaoman Gu
OPPOSITION- D27 - Copy of corrected, certified priority document
OPPOSITION- D28 - Sequence listing of priority document P1: reordered pages
OPPOSITION- D30 - Declaration of Prachand Shrestha
OPPOSITION- Harris Annie Deborah, Ramalingam C, "Xylanases and its Application in Food Industry: A Review", Journal of Experimental Sciences, (20101231), vol. 1, no. 7, ISSN 2218-1768, pages 1 - 11, XP093212359
OPPOSITION- David Van Eylen, Femke Van Dongen, Mirjam Kabel, Jan De Bont, "Corn fiber, cobs and stover: Enzyme-aided saccharification and co-fermentation after dilute acid pretreatment", Bioresource Technology, Elsevier, (20110501), vol. 102, no. 10, doi:10.1016/j.biortech.2011.02.049, ISSN 09608524, pages 5995 - 6004, XP055014088
OPPOSITION- Franz J. St John; Javier M. González; Edwin Pozharski, "Consolidation of glycosyl hydrolase family 30: A dual domain 4/7 hydrolase family consisting of two structurally distinct groups", FEBS Letters, ELSEVIER, AMSTERDAM., NL, NL , (20101008), vol. 584, no. 21, doi:10.1016/j.febslet.2010.09.051, ISSN 0014-5793, pages 4435 - 4441, XP071251652
OPPOSITION- Collins T, Gerday C, Feller G., "Xylanases, xylanase families and extremophilic xylanases.", FEMS MICROBIOLOGY REVIEWS, ELSEVIER, AMSTERDAM; NL, AMSTERDAM; NL , (20050101), vol. 29, no. 1, doi:10.1016/j.femsre.2004.06.005, ISSN 0168-6445, pages 3 - 23, XP002736529
OPPOSITION- Miyauchi Shingo, Te’o V.S., Bergquist Peter L., Nevalainen K.M. Helena, "Expression of a bacterial xylanase in Trichoderma reesei under the egl2 and cbh2 glycosyl hydrolase gene promoters", New BIOTECHNOLOGY, ELSEVIER BV, NL, NL , (20130601), vol. 30, no. 5, doi:10.1016/j.nbt.2013.02.005, ISSN 1871-6784, pages 523 - 530, XP093246414
OPPOSITION- Burke Sean V., Wysocki William P., Zuloaga Fernando O., Craine Joseph M., Pires J. Chris, Edger Patrick P., Mayfield-Jones Dustin, Clark Lynn G., Kelchner Scot A., Duvall Melvin R., "Evolutionary relationships in Panicoid grasses based on plastome phylogenomics (Panicoideae; Poaceae)", BMC PLANT BIOLOGY, BIOMED CENTRAL, LONDON, GB, GB , (20161201), vol. 16, no. 1, doi:10.1186/s12870-016-0823-3, ISSN 1471-2229, XP093246412
OPPOSITION- Zhang Shu, Zhao Sha, Shang Weihao, Yan Zijuan, Wu Xiuyun, Li Yingjie, Chen Guanjun, Liu Xinli, Wang Lushan, "Synergistic mechanism of GH11 xylanases with different action modes from Aspergillus niger An76", Biotechnology for Biofuels, (20211201), vol. 14, no. 1, doi:10.1186/s13068-021-01967-1, ISSN 1754-6834, XP093246416
OPPOSITION- VINZANT T B,ET AL, "Fingerprinting Trichoderma reesei hydrolases in a commercial cellulase preparation", APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, Humana Press Inc, New York, New York , (20010401), vol. 91-93, doi:10.1385/ABAB:91-93:1-9:99, ISSN 0273-2289, pages 99 - 107, XP002361076

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents